Sign in

CIK 0001681682

  • Non-accelerated filer
  • Smaller reporting company

ENDRA Life Sciences Inc.

Sign in to watch
Ticker
NDRA
Exchange
Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
260579295
Phone
+1 734-335-0468
Business address
3600 GREEN COURT, SUITE 350, ANN ARBOR, MI, 48105
Former names
Endra Inc.
  1. 4 Grant or award Chief Commercial Officer acquired 86,580 shares (grant or award)
  2. 4 Grant or award Chief Financial Officer acquired 79,653 shares (grant or award)
  3. 4 Grant or award Chief Technology Officer acquired 96,213 shares (grant or award)
  4. 4 Grant or award Chief Executive Officer acquired 123,064 shares (grant or award)
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Grant or award Director acquired 100,503 shares (grant or award)
  19. 4 Open-market buy Chief Financial Officer bought 10,000 shares at $1.18 ($11,800)
  20. 4 Open-market buy Chief Financial Officer bought 10,000 shares at an average $1.56 ($15,550)

Page 6 of 9 · 174 filings